Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 261

1.

Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis.

Rupoli S, Goteri G, Picardi P, Micucci G, Canafoglia L, Scortechini AR, Federici I, Giantomassi F, Da Lio L, Zizzi A, Honorati E, Leoni P.

Diagn Pathol. 2015 Apr 16;10(1):29. doi: 10.1186/s13000-015-0269-1.

2.

Primary B-cell lymphoblastic lymphoma of the testis.

Tombolini F, Lacetera V, Gini G, Capelli D, Leoni P, Montironi R, Galosi AB, Muzzonigro G.

Arch Ital Urol Androl. 2014 Dec 30;86(4):400-1. doi: 10.4081/aiua.2014.4.400.

PMID:
25641484
3.

Biosafety evidence for human dedifferentiated adipocytes.

Poloni A, Maurizi G, Mattiucci D, Busilacchi E, Mancini S, Discepoli G, Amici A, Falconi M, Cinti S, Leoni P.

J Cell Physiol. 2015 Jul;230(7):1525-33. doi: 10.1002/jcp.24898.

PMID:
25641257
4.

Fatal necrotizing angiotropic Epstein-Barr virus-negative large B-cell lymphoma: a case report with unusual clinicopathological features in-between lymphomatoid granulomatosis and T-cell/histiocyte-rich large B-cell lymphoma.

Olivieri A, Sabattini E, Goteri G, Trappolini S, Saraceni F, Samorì A, Gini G, Leoni P, Olivieri J, Pileri SA.

Medicine (Baltimore). 2014 Dec;93(29):e353. doi: 10.1097/MD.0000000000000353.

PMID:
25546693
5.

Plasticity of human dedifferentiated adipocytes toward endothelial cells.

Poloni A, Maurizi G, Anastasi S, Mondini E, Mattiucci D, Discepoli G, Tiberi F, Mancini S, Partelli S, Maurizi A, Cinti S, Olivieri A, Leoni P.

Exp Hematol. 2015 Feb;43(2):137-46. doi: 10.1016/j.exphem.2014.10.003. Epub 2014 Oct 24.

PMID:
25448487
6.

An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma.

Offidani M, Corvatta L, Caraffa P, Gentili S, Maracci L, Leoni P.

Onco Targets Ther. 2014 Sep 29;7:1793-800. doi: 10.2147/OTT.S49187. eCollection 2014. Review.

7.

Glial-like differentiation potential of human mature adipocytes.

Poloni A, Maurizi G, Foia F, Mondini E, Mattiucci D, Ambrogini P, Lattanzi D, Mancini S, Falconi M, Cinti S, Olivieri A, Leoni P.

J Mol Neurosci. 2015 Jan;55(1):91-8. doi: 10.1007/s12031-014-0345-0. Epub 2014 Jul 10.

PMID:
25007949
8.

Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes.

Poloni A, Maurizi G, Mattiucci D, Amatori S, Fogliardi B, Costantini B, Mariani M, Mancini S, Olivieri A, Fanelli M, Leoni P.

Leukemia. 2014 Nov;28(11):2241-4. doi: 10.1038/leu.2014.197. Epub 2014 Jun 19. No abstract available.

PMID:
24943834
9.

Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicin.

Capelli D, Chiarucci M, Poloni A, Saraceni F, Mancini G, Trappolini S, Troiani E, Montanari M, Scortechini I, Offidani M, Rupoli S, Scortechini AR, Gini G, Discepoli G, Leoni P, Olivieri A.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1399-406. doi: 10.1016/j.bbmt.2014.05.019. Epub 2014 May 28.

PMID:
24880020
10.

Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data.

Offidani M, Corvatta L, Caraffa P, Leoni P, Pautasso C, Larocca A, Palumbo A.

Expert Rev Anticancer Ther. 2014 May;14(5):499-510. doi: 10.1586/14737140.2014.906904. Epub 2014 Apr 17. Review.

PMID:
24738833
11.

Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.

Messori L, Marchetti L, Massai L, Scaletti F, Guerri A, Landini I, Nobili S, Perrone G, Mini E, Leoni P, Pasquali M, Gabbiani C.

Inorg Chem. 2014 Mar 3;53(5):2396-403. doi: 10.1021/ic401731a. Epub 2014 Feb 18.

PMID:
24547701
12.

20 × 960-Gb/s Space-division-multiplexed 32QAM transmission over 60 km few-mode fiber.

Sleiffer VA, Leoni P, Jung Y, Surof J, Kuschnerov M, Veljanovski V, Alam SU, Richardson DJ, Grüner-Nielsen L, Sun Y, Corbett B, Winfield R, Calabrò S, de Waardt H.

Opt Express. 2014 Jan 13;22(1):749-55. doi: 10.1364/OE.22.000749.

PMID:
24515034
13.

Field demonstration of mode-division multiplexing upgrade scenarios on commercial networks.

Sleiffer VA, Chen H, Jung Y, Leoni P, Kuschnerov M, Simperler A, Fabian H, Schuh H, Kub F, Richardson DJ, Alam SU, Grüner-Nielsen L, Sun Y, Koonen AM, de Waardt H.

Opt Express. 2013 Dec 16;21(25):31036-46. doi: 10.1364/OE.21.031036.

PMID:
24514678
14.

Valproic acid for the treatment of low-risk myelodysplastic syndromes: A case report and a review of the literature.

Poloni A, Costantini B, Mariani M, Leoni P.

Leuk Res Rep. 2013 Jun 11;2(2):44-6. doi: 10.1016/j.lrr.2013.03.003. eCollection 2013.

15.

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

Willemze R, Suciu S, Meloni G, Labar B, Marie JP, Halkes CJ, Muus P, Mistrik M, Amadori S, Specchia G, Fabbiano F, Nobile F, Sborgia M, Camera A, Selleslag DL, Lefrère F Sr, Magro D, Sica S, Cantore N, Beksac M, Berneman Z, Thomas X, Melillo L, Guimaraes JE, Leoni P, Luppi M, Mitra ME, Bron D, Fillet G, Marijt EW, Venditti A, Hagemeijer A, Mancini M, Jansen J, Cilloni D, Meert L, Fazi P, Vignetti M, Trisolini SM, Mandelli F, de Witte T.

J Clin Oncol. 2014 Jan 20;32(3):219-28. doi: 10.1200/JCO.2013.51.8571. Epub 2013 Dec 2.

16.

The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.

Morelli MB, Offidani M, Alesiani F, Discepoli G, Liberati S, Olivieri A, Santoni M, Santoni G, Leoni P, Nabissi M.

Int J Cancer. 2014 Jun 1;134(11):2534-46. doi: 10.1002/ijc.28591. Epub 2013 Dec 2.

PMID:
24293211
17.

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

Offidani M, Corvatta L, Maracci L, Liberati AM, Ballanti S, Attolico I, Caraffa P, Alesiani F, Caravita di Toritto T, Gentili S, Tosi P, Brunori M, Derudas D, Ledda A, Gozzetti A, Cellini C, Malerba L, Mele A, Andriani A, Galimberti S, Mondello P, Pulini S, Coppetelli U, Fraticelli P, Olivieri A, Leoni P.

Blood Cancer J. 2013 Nov 22;3:e162. doi: 10.1038/bcj.2013.58.

18.

Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey.

Olivieri J, Pierelli L, Introna M, Accorsi P, Bosi A, Perseghin P, Risso M, Pandolfi A, Mancini S, Marchetti M, Dal Pozzo S, Gotti E, Rambaldi A, Leoni P, Olivieri A; Gitmo (Gruppo Italiano Trapianto di Midollo Osseo)–SIDEM (Società Italiana di Emaferesi e Manipolazione Cellulare) Working Group on SCU Disposal.

Cytotherapy. 2014 Jan;16(1):101-10. doi: 10.1016/j.jcyt.2013.07.001. Epub 2013 Oct 26.

PMID:
24169075
19.

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

Olivieri A, Cimminiello M, Corradini P, Mordini N, Fedele R, Selleri C, Onida F, Patriarca F, Pavone E, Svegliati S, Gabrielli A, Bresciani P, Nuccorini R, Pascale S, Coluzzi S, Pane F, Poloni A, Olivieri J, Leoni P, Bacigalupo A.

Blood. 2013 Dec 12;122(25):4111-8. doi: 10.1182/blood-2013-05-494278. Epub 2013 Oct 23.

20.

Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome.

Poloni A, Serrani F, Berardinelli E, Maurizi G, Mariani M, Costantini B, Trappolini S, Mancini S, Olivieri A, Leoni P.

Leuk Res. 2013 Nov;37(11):1538-44. doi: 10.1016/j.leukres.2013.07.022. Epub 2013 Oct 3.

PMID:
24095110
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk